Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Vitamin A status has been assessed by studying plasma vitamin A and retinol binding protein (RBP) levels in premature infants receiving 7,500 IU vitamin A/d (RDA 660-3,300 IU/d) and in control term babies during the 3 first months of life. Sampling was performed within the first week (D0-D7), between the 8th and the 30th day (D8-D30) and during the 2nd and the 3rd month of life (M2-M3). At D0-D7, vitamin A levels of the
PTI
group (28-32 weeks gestational age), PTII (33-36 weeks GA) and AT (control term newborn) were 242.1 +/- 20.5 (X +/-
SEM
), 176.1 +/- 12.3 and 213.1 +/- 17.1 micrograms/l respectively (P = 0.005). At D8-D30, these values were 264.2 +/- 26.0, 270.4 +/- 21.6 and 242.6 +/- 24.5 micrograms/l respectively (NS), and at M2-M3 234.2 +/- 21.6, 282.1 +/- 18.5 and 292.1 +/- 31.5 micrograms/l (NS). A significant difference was found between the values of the different dosage periods for PTII and AT groups; no difference in RBP levels was found either between groups or between dosage periods. At birth, our results show that the RBP synthesis is not closely linked to gestational age. The plasma vitamin A levels which rely on foetal stores and therefore on transplacental passage and on peripheral tissue requirements are low at 33-36 weeks gestational age. With a 7,500 IU daily supplement, excessively high vitamin A levels were not observed in premature infants; vitamin A and RBP levels in premature infants receiving supplement are not different from controls despite the 8-12-week term high vitamin A supply.
...
PMID:[Vitamin A status in full-term and premature infants]. 217 49
The phosphor of CeO2 activated with the trivalent rare-earth Sm3+ ions were synthesized by using a solvothermal method. The CeO2:Sm3+ powders were finally obtained through calcination process sintered in the air at 800-1200 degrees C. The synthesized phosphors were characterized systematically by X-ray diffraction (XRD), field emission scanning electron microscopy (FE-SEM), photoluminescence (PL) and photoluminescence excitation spectra (PLE). The XRD and FE-
SEM
results reveal that the phosphor exhibit agglomerated spherical shape and with the increase of sintering temperature peaks become sharper and narrower and the crystal sizes also increase, respectively. The room temperature photoluminescence spectra of Sm3+ doped CeO2 powders were recorded on a
PTI
(Photon Technology International) flurimeter using a Xe-arc lamp with a power of 60 W. The emitted radiation was dominated by the orange light with the characteristic emission of Sm3+ from the transitions of 4G5/2 --> 6H5/2,7/2. The sharp emission properties show that the CeO2 has the potential to serve as a host material for rare-earth doped laser crystal and phosphor material.
...
PMID:Crystal growth and photoluminescence properties of Sm3+ doped CeO2 nanophosphors by solvothermal method. 2420 99